Home › Funds › Invenomic Capital Management LP › CRM

Invenomic Capital Management LP position in CRM

SALESFORCE INC · Technology

Invenomic Capital Management LP reported holding 193,300 shares of CRM (SALESFORCE INC) in its Q2 2026 13F filing — a position valued at US$30.3M, representing 1.81% of its reported portfolio and ranking #15 among its reported holdings. Invenomic Capital Management LP has disclosed CRM holdings in 6 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)193.30K sh
Reported value held$30.28M
Portfolio Weight1.81%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Invenomic Capital Management LP's CRM position evolved

Invenomic Capital Management LP first disclosed a stake in CRM in Q3 2024 at 39,250 shares (US$10.7M). The position peaked in Q1 2026 at 223,542 shares, worth US$41.7M. Across 6 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 193,300 shares valued at US$30.3M — a reduction of -30,242 shares quarter over quarter.. Notable position changes include a 140% increase in Q3 2025 (shares rose 12% over the following quarter), a 400% increase in Q1 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 39.25K $10.74M New
Q2 2025 19.02K $5.19M New
Q3 2025 45.73K $10.84M Add
Q4 2025 44.71K $11.84M Reduce
Q1 2026 223.54K $41.73M Add
Q2 2026 193.30K $30.28M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRM and 13F data

CRM (SALESFORCE INC) is a Technology company. 18 other funds we track also report a position in CRM — the largest reported positions include Vanguard Group (US$23.80B), Harris Associates (Oakmark) (US$2.53B), HARRIS ASSOCIATES L P (US$2.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRM

All CRM fund holders →

FAQ

How long has Invenomic Capital Management LP held CRM?

Invenomic Capital Management LP has disclosed CRM holdings in 6 of the last 8 reported quarters, going back to Q3 2024.

What is Invenomic Capital Management LP's current position in CRM?

As of Q2 2026, Invenomic Capital Management LP holds 193.30K shares of CRM (SALESFORCE INC), valued at $30.28M, representing 1.81% of its reported portfolio and ranking #15.

Has Invenomic Capital Management LP been buying or selling CRM?

In the latest 13F filing (Q2 2026), Invenomic Capital Management LP reduced its position in CRM. The position peaked in Q1 2026 at 223.54K shares.

Which other funds hold CRM?

Other major institutional holders of CRM include Vanguard Group, Harris Associates (Oakmark), HARRIS ASSOCIATES L P, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.